Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for STOK

Stock Name	Stoke Therapeutics Inc
Ticker	STOK(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US86150R1077
LEI	549300RD25SS2DIJHJ67

Show aggregate STOK holdings

News associated with STOK

Notable Wednesday Option Activity: AAPL, STOK, Z: Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Apple Inc (Symbol: AAPL), where a total volume of 543,181 contracts has been traded thus far today, a contract volume which is representative of approximately 54 - 2025-09-17 16:17:22
7 Biotech Stocks Trading At 52-Week Highs - Can The Rally Continue?: (RTTNews) - Patience is a virtue - important in all aspects of life, and especially crucial when it comes to investing. As trading expert Steve Burns once said, "Much of our trading comes down to a battle between our patience and our impulses." - 2025-09-15 03:55:16
Analysts Set Stoke Therapeutics, Inc. (NASDAQ:STOK) PT at $25.57: Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has earned an average rating of “Buy” from the nine ratings firms that are covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12-month target price among […] - 2025-08-22 03:12:53
Stoke Therapeutics (NASDAQ:STOK) Shares Gap Up on Better-Than-Expected Earnings: Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s share price gapped up before the market opened on Wednesday following a better than expected earnings announcement. The stock had previously closed at $13.53, but opened at $14.89. Stoke Therapeutics shares last traded at $15.14, with a volume of 236,029 shares changing hands. The company reported ($0.40) […] - 2025-08-15 02:34:48
40,181 Shares in Stoke Therapeutics, Inc. (NASDAQ:STOK) Acquired by XTX Topco Ltd: XTX Topco Ltd purchased a new stake in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) during the 1st quarter, HoldingsChannel reports. The fund purchased 40,181 shares of the company’s stock, valued at approximately $267,000. Other large investors have also recently bought and sold shares of the company. RTW Investments LP raised its position in Stoke […] - 2025-08-12 04:30:53
Brokerages Set Stoke Therapeutics, Inc. (NASDAQ:STOK) Target Price at $25.80: Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has received an average recommendation of “Buy” from the seven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year price […] - 2025-07-28 02:30:54
Stoke Therapeutics (NASDAQ:STOK) Shares Gap Up – Here’s What Happened: Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $12.35, but opened at $12.93. Stoke Therapeutics shares last traded at $12.75, with a volume of 96,492 shares traded. Wall Street Analyst Weigh In A number of research analysts have recently weighed […] - 2025-07-20 05:22:59
Alps Advisors Inc. Sells 2,940 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK): Alps Advisors Inc. decreased its stake in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 6.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,890 shares of the company’s stock after selling 2,940 shares during the period. Alps Advisors Inc.’s holdings […] - 2025-07-18 05:21:01
Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Rating of “Buy” by Brokerages: Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) have been assigned an average recommendation of “Buy” from the seven analysts that are covering the firm, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average […] - 2025-06-30 02:34:50
Assenagon Asset Management S.A. Cuts Stake in Stoke Therapeutics, Inc. (NASDAQ:STOK): Assenagon Asset Management S.A. lowered its position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 29.0% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 959,603 shares of the company’s stock after selling 391,322 shares during the period. Assenagon Asset Management S.A.’s holdings in Stoke Therapeutics were worth $6,381,000 as of […] - 2025-06-15 05:44:52
Stoke Therapeutics, Inc. (NASDAQ:STOK) Shares Sold by BNP Paribas Financial Markets: BNP Paribas Financial Markets decreased its position in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 94.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,422 shares of the company’s stock after selling 71,732 shares during the quarter. BNP Paribas Financial […] - 2025-06-04 05:14:48
Legal & General Group Plc Has $390,000 Stock Position in Stoke Therapeutics, Inc. (NASDAQ:STOK): Legal & General Group Plc trimmed its position in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 5.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,347 shares of the company’s stock after selling 2,139 shares during the quarter. Legal & General […] - 2025-05-01 04:42:53
Renaissance Technologies LLC Buys Shares of 129,043 Stoke Therapeutics, Inc. (NASDAQ:STOK): Renaissance Technologies LLC purchased a new position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 129,043 shares of the company’s stock, valued at approximately $1,423,000. Other large investors have […] - 2025-04-29 04:58:53
Stoke Therapeutics (NASDAQ:STOK) Receives “Buy” Rating from Needham & Company LLC: Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Needham & Company LLC in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $22.00 price objective on the stock. Needham & Company LLC’s price objective suggests a potential upside of 237.42% from […] - 2025-04-11 04:46:50
HC Wainwright Reaffirms “Buy” Rating for Stoke Therapeutics (NASDAQ:STOK): Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $47.00 price objective on the stock. HC Wainwright’s price target indicates a potential upside of 464.23% from the stock’s previous close. HC […] - 2025-03-21 04:25:10
Stoke Therapeutics (NASDAQ:STOK) Earns Buy Rating from Needham & Company LLC: Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Needham & Company LLC in a report released on Tuesday,Benzinga reports. They presently have a $22.00 target price on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 166.34% from the stock’s […] - 2025-03-20 04:44:48
Brokerages Set Stoke Therapeutics, Inc. (NASDAQ:STOK) Target Price at $23.00: Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) have earned an average rating of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy […] - 2025-02-28 04:26:56
Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives $21.29 Average Target Price from Brokerages: Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has earned an average recommendation of “Buy” from the ten analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy recommendation on the company. The […] - 2025-02-03 04:24:54

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) STOK holdings

Date	Number of STOK Shares Held	Base Market Value of STOK Shares	Local Market Value of STOK Shares	Change in STOK Shares Held	Change in STOK Base Value	Current Price per STOK Share Held	Previous Price per STOK Share Held
2025-11-11 (Tuesday)	35,903	USD 901,524	USD 901,524	0	USD 98,374	USD 25.11	USD 22.37
2025-11-10 (Monday)	35,903	USD 803,150	USD 803,150	92	USD -15,489	USD 22.37	USD 22.86
2025-11-07 (Friday)	35,811	USD 818,639	USD 818,639	0	USD 13,966	USD 22.86	USD 22.47
2025-11-06 (Thursday)	35,811	USD 804,673	USD 804,673	92	USD -10,435	USD 22.47	USD 22.82
2025-11-05 (Wednesday)	35,719	USD 815,108	USD 815,108	0	USD -90,011	USD 22.82	USD 25.34
2025-11-04 (Tuesday)	35,719	USD 905,119	USD 905,119	92	USD -24,746	USD 25.34	USD 26.1
2025-11-03 (Monday)	35,627	USD 929,865	USD 929,865	0	USD -140,370	USD 26.1	USD 30.04
2025-10-31 (Friday)	35,627	USD 1,070,235	USD 1,070,235	0	USD -59,141	USD 30.04	USD 31.7
2025-10-30 (Thursday)	35,627	USD 1,129,376	USD 1,129,376	460	USD 24,781	USD 31.7	USD 31.41
2025-10-29 (Wednesday)	35,167	USD 1,104,595	USD 1,104,595	184	USD -1,917	USD 31.41	USD 31.63
2025-10-28 (Tuesday)	34,983	USD 1,106,512	USD 1,106,512	0	USD -47,927	USD 31.63	USD 33
2025-10-27 (Monday)	34,983	USD 1,154,439	USD 1,154,439	0	USD 25,188	USD 33	USD 32.28

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of STOK by Blackrock for IE00BDZVHG35

Show aggregate share trades of STOK

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 92 22.370* 13.26
2025-11-06 BUY 92 22.470* 13.13
2025-11-04 BUY 92 25.340* 12.99
2025-10-30 BUY 460 32.550 31.000 31.155 USD 14,331 12.65
2025-10-29 BUY 184 31.410 32.595 32.477 USD 5,976 12.53
2025-10-22 SELL -368 32.520 34.855 34.621 USD -12,741 11.83 Loss of -8,389 on sale
2025-10-20 BUY 184 34.650 35.190 35.136 USD 6,465 11.50
2025-10-17 BUY 460 33.530 34.730 34.610 USD 15,921 11.34
2025-10-15 BUY 736 35.600 37.670 37.463 USD 27,573 11.16
2025-10-03 BUY 644 25.560 25.610 25.605 USD 16,490 10.88
2025-10-02 BUY 93 24.820 24.830 24.829 USD 2,309 10.77
2025-09-30 BUY 184 23.500 24.970 24.823 USD 4,567 10.58
2025-09-26 BUY 186 24.140 24.345 24.324 USD 4,524 10.37
2025-09-25 BUY 186 22.950 23.723 23.646 USD 4,398 10.27
2025-09-18 BUY 93 23.500 23.820 23.788 USD 2,212 10.17
2025-09-17 BUY 279 22.740 23.675 23.581 USD 6,579 10.07
2025-09-11 SELL -93 23.880 24.000 23.988 USD -2,231 9.85 Loss of -1,315 on sale
2025-09-10 BUY 186 22.660 22.790 22.777 USD 4,237 9.75
2025-07-17 SELL -186 12.350 12.390 12.386 USD -2,304 9.57 Loss of -523 on sale
2025-07-11 SELL -744 11.860 12.030 12.013 USD -8,938 9.49 Loss of -1,874 on sale
2025-07-02 BUY 5,115 11.550 11.860 11.829 USD 60,505 9.41
2025-06-25 BUY 186 11.810 11.900 11.891 USD 2,212 9.33
2025-06-11 BUY 188 11.500 11.810 11.779 USD 2,214 9.10
2025-06-10 BUY 188 11.360 11.480 11.468 USD 2,156 9.08
2025-06-04 SELL -94 10.940 11.420 11.372 USD -1,069 8.99 Loss of -224 on sale
2025-04-23 BUY 94 9.520 9.900 9.862 USD 927 8.73
2025-04-10 SELL -760 6.520 6.550 6.547 USD -4,976 8.90 Profit of 1,786 on sale
2025-04-08 SELL -95 5.900 6.340 6.296 USD -598 9.00 Profit of 257 on sale
2025-04-07 SELL -95 6.010 6.170 6.154 USD -585 9.06 Profit of 276 on sale
2025-04-04 SELL -480 5.940 6.200 6.174 USD -2,964 9.12 Profit of 1,415 on sale
2025-04-01 BUY 384 6.230 6.730 6.680 USD 2,565 9.24
2025-03-31 SELL -288 6.650 7.080 7.037 USD -2,027 9.29 Profit of 649 on sale
2025-03-21 BUY 2,806 8.150 8.350 8.330 USD 23,374 9.52
2025-03-14 SELL -1,392 8.600 8.715 8.704 USD -12,115 9.65 Profit of 1,316 on sale
2025-03-07 SELL -174 8.010 8.210 8.190 USD -1,425 9.89 Profit of 296 on sale
2025-03-04 SELL -87 7.580 7.690 7.679 USD -668 10.10 Profit of 210 on sale
2025-02-25 BUY 174 8.250 8.630 8.592 USD 1,495 10.56
2025-02-19 SELL -86 9.300 9.940 9.876 USD -849 10.95 Profit of 92 on sale
2025-02-13 BUY 255 10.630 10.640 10.639 USD 2,713 11.09
2025-02-12 BUY 85 10.260 10.350 10.341 USD 879 11.15
2025-02-11 BUY 340 10.320 10.360 10.356 USD 3,521 11.21
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	92			22.370*		13.26
2025-11-06	BUY	92			22.470*		13.13
2025-11-04	BUY	92			25.340*		12.99
2025-10-30	BUY	460	32.550	31.000	31.155	USD 14,331	12.65
2025-10-29	BUY	184	31.410	32.595	32.477	USD 5,976	12.53
2025-10-22	SELL	-368	32.520	34.855	34.621	USD -12,741	11.83 Loss of -8,389 on sale
2025-10-20	BUY	184	34.650	35.190	35.136	USD 6,465	11.50
2025-10-17	BUY	460	33.530	34.730	34.610	USD 15,921	11.34
2025-10-15	BUY	736	35.600	37.670	37.463	USD 27,573	11.16
2025-10-03	BUY	644	25.560	25.610	25.605	USD 16,490	10.88
2025-10-02	BUY	93	24.820	24.830	24.829	USD 2,309	10.77
2025-09-30	BUY	184	23.500	24.970	24.823	USD 4,567	10.58
2025-09-26	BUY	186	24.140	24.345	24.324	USD 4,524	10.37
2025-09-25	BUY	186	22.950	23.723	23.646	USD 4,398	10.27
2025-09-18	BUY	93	23.500	23.820	23.788	USD 2,212	10.17
2025-09-17	BUY	279	22.740	23.675	23.581	USD 6,579	10.07
2025-09-11	SELL	-93	23.880	24.000	23.988	USD -2,231	9.85 Loss of -1,315 on sale
2025-09-10	BUY	186	22.660	22.790	22.777	USD 4,237	9.75
2025-07-17	SELL	-186	12.350	12.390	12.386	USD -2,304	9.57 Loss of -523 on sale
2025-07-11	SELL	-744	11.860	12.030	12.013	USD -8,938	9.49 Loss of -1,874 on sale
2025-07-02	BUY	5,115	11.550	11.860	11.829	USD 60,505	9.41
2025-06-25	BUY	186	11.810	11.900	11.891	USD 2,212	9.33
2025-06-11	BUY	188	11.500	11.810	11.779	USD 2,214	9.10
2025-06-10	BUY	188	11.360	11.480	11.468	USD 2,156	9.08
2025-06-04	SELL	-94	10.940	11.420	11.372	USD -1,069	8.99 Loss of -224 on sale
2025-04-23	BUY	94	9.520	9.900	9.862	USD 927	8.73
2025-04-10	SELL	-760	6.520	6.550	6.547	USD -4,976	8.90 Profit of 1,786 on sale
2025-04-08	SELL	-95	5.900	6.340	6.296	USD -598	9.00 Profit of 257 on sale
2025-04-07	SELL	-95	6.010	6.170	6.154	USD -585	9.06 Profit of 276 on sale
2025-04-04	SELL	-480	5.940	6.200	6.174	USD -2,964	9.12 Profit of 1,415 on sale
2025-04-01	BUY	384	6.230	6.730	6.680	USD 2,565	9.24
2025-03-31	SELL	-288	6.650	7.080	7.037	USD -2,027	9.29 Profit of 649 on sale
2025-03-21	BUY	2,806	8.150	8.350	8.330	USD 23,374	9.52
2025-03-14	SELL	-1,392	8.600	8.715	8.704	USD -12,115	9.65 Profit of 1,316 on sale
2025-03-07	SELL	-174	8.010	8.210	8.190	USD -1,425	9.89 Profit of 296 on sale
2025-03-04	SELL	-87	7.580	7.690	7.679	USD -668	10.10 Profit of 210 on sale
2025-02-25	BUY	174	8.250	8.630	8.592	USD 1,495	10.56
2025-02-19	SELL	-86	9.300	9.940	9.876	USD -849	10.95 Profit of 92 on sale
2025-02-13	BUY	255	10.630	10.640	10.639	USD 2,713	11.09
2025-02-12	BUY	85	10.260	10.350	10.341	USD 879	11.15
2025-02-11	BUY	340	10.320	10.360	10.356	USD 3,521	11.21

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of STOK

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	262,760	120	369,781	71.1%
2025-09-18	345,578	6,230	402,474	85.9%
2025-09-17	259,773	0	416,703	62.3%
2025-09-16	82,952	0	261,951	31.7%
2025-09-15	127,587	993	276,305	46.2%
2025-09-12	255,262	3,603	365,375	69.9%
2025-09-11	300,167	8,555	440,705	68.1%
2025-09-10	353,400	0	484,109	73.0%
2025-09-09	183,646	100	292,153	62.9%
2025-09-08	329,798	0	585,233	56.4%
2025-09-05	98,134	10	194,324	50.5%
2025-09-04	122,399	505	235,777	51.9%
2025-09-03	222,505	23	315,410	70.5%
2025-09-02	258,382	703	412,066	62.7%
2025-08-29	160,764	424	219,706	73.2%
2025-08-28	149,055	0	220,197	67.7%
2025-08-27	116,276	13,373	208,155	55.9%
2025-08-26	389,100	479	772,802	50.3%
2025-08-25	120,687	1,219	207,751	58.1%
2025-08-22	132,525	7,377	305,663	43.4%
2025-08-21	183,477	0	320,429	57.3%
2025-08-20	177,477	1,472	319,663	55.5%
2025-08-19	233,847	443	570,003	41.0%
2025-08-18	266,157	2,972	393,813	67.6%
2025-08-15	325,620	13,531	744,113	43.8%
2025-08-14	465,564	1,736	679,942	68.5%
2025-08-13	689,376	127	1,184,978	58.2%
2025-08-12	91,216	0	155,563	58.6%
2025-08-11	66,965	39	112,390	59.6%
2025-08-08	82,362	0	126,449	65.1%
2025-08-07	87,291	21	136,049	64.2%
2025-08-06	212,281	190	318,905	66.6%
2025-08-05	89,249	0	120,250	74.2%
2025-08-04	100,923	0	144,550	69.8%
2025-08-01	87,655	0	133,696	65.6%
2025-07-31	101,691	0	146,686	69.3%
2025-07-30	87,857	0	136,030	64.6%
2025-07-29	120,439	100	375,067	32.1%
2025-07-28	151,571	3,048	240,590	63.0%
2025-07-25	168,182	1,866	331,958	50.7%
2025-07-24	248,649	116	499,350	49.8%
2025-07-23	401,884	19	652,146	61.6%
2025-07-22	581,247	292	1,255,404	46.3%
2025-07-21	177,262	0	270,205	65.6%
2025-07-18	428,131	0	678,550	63.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE